Multidrug resistance reversal properties and cytotoxic evaluation of representatives of a novel class of HIV-1 protease inhibitors (Q39635266)

13 September 2017

title

Multidrug resistance reversal properties and cytotoxic evaluation of representatives of a novel class of HIV-1 protease inhibitors (English)

1 reference

13 September 2017

main subject

multiple drug resistance

1 reference

Claudius Coburger

1

1 reference

13 September 2017

Hermann Lage

2

1 reference

13 September 2017

Joséf Molnár

3

1 reference

13 September 2017

Andreas Langner

4

1 reference

13 September 2017

Andreas Hilgeroth

5

1 reference

13 September 2017

publication date

4 October 2010

1 reference

Journal of Pharmacy and Pharmacology

13 September 2017

published in

1 reference

13 September 2017

volume

62

1 reference

13 September 2017

issue

12

1 reference

13 September 2017

page(s)

1704-1710

1 reference

Multidrug resistance: can new drugs help chemotherapy score against cancer?

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Resistance mechanisms associated with altered intracellular distribution of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Crystal structure of bacterial multidrug efflux transporter AcrB

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Preface: the concept and consequences of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Recent advances in the development of P-gp inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

ABC multidrug transporters: structure, function and role in chemoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Thermosensitivity of multidrug-resistant human gastric and pancreatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Novel insight in structure-activity relationship and bioanalysis of P-glycoprotein targeting highly potent tetrakishydroxymethyl substituted 3,9-diazatetraasteranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Biotransformation and toxicity of the lipoxygenase inhibitor 2-hydroxy-5-methyllaurophenone oxime (FLM 5011) on Hep G2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Reservoirs, sanctuaries, and residual disease: the hiding spots of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Rapid Identification of P-glycoprotein Substrates and Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

Novel Insight into Inhibitor Binding of Highly Symmetric HIV-1 Protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2010.01144.X

10.1111/J.2042-7158.2010.01144.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference